Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 11;12(5):716.
doi: 10.3390/life12050716.

New Insights into Hematopoietic Stem Cell Expansion to Stimulate Repopulation of the Adult Blood System for Transplantation

Affiliations
Review

New Insights into Hematopoietic Stem Cell Expansion to Stimulate Repopulation of the Adult Blood System for Transplantation

Jiangying Xuan et al. Life (Basel). .

Abstract

Successful engraftment of hematopoietic stem cells (HSCs) and progenitor cells (HSPCs) may be considered as a basis for the repopulation of the blood cells after transplantation in adults. Therefore, in vivo and ex vivo expansion of HSCs holds great promise for clinical applications. In this review, the mechanisms of HSC expansion will be discussed, considering the previous studies and works of literature. This is aimed to identify the signaling pathways that regulate HSC expansion and improve the application of engraftment in disease management. The following aspects will be included: (i) Stimulation of HSCs growth in vivo through gene regulation and cytokines activation; (ii) direct or indirect induction of HSC expansion by regulating signaling pathways; (iii) addition to assisting cells to help in the proliferation of HSCs; (iv) changing of living environment in the HSCs cultures via adjusting components and forms of cultures; (v) enhancement of HSC expansion by incorporating substances, such as extracellular vesicles (EVs), UM171, among others. In this review, recent new findings that provide us with new insights into HSC expansion methods have been summarized. Furthermore, these findings will also provide more possibilities for the development of some novel strategies for expanding and engrafting HSCs applied for treatments of some hematopoietic disorders.

Keywords: cultures; ex vivo expansion; hematopoietic stem cells; in vivo expansion; microenvironment regulation; signaling pathway.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
ZBTB7A acts on the process with HSCs’ differentiation and glycolytic pathways to regulate HSC expansion. In HSC differentiation, ZBTB7A mutations disturb myeloid HSCs and HSPC differentiation. In the glycolytic pathway, ZBTB7A with RUNX1-RUNX1T1 fusion gene can downregulate MYC and PKM2 to promote glycolysis and sensitize leukemic blasts.
Figure 2
Figure 2
Overview of signaling pathways involved in HSC expansion. Shh, GSK3, TGF-b, Notch and Hox signaling pathways are the basic pathways that regulate HSC expansion via affecting cell differentiation and circumstances. Signaling pathways have both positive and negative effects on HSC amplification.
Figure 3
Figure 3
Overview of substances that expand HSCs in vitro. Substances can be classified into 3 categories based on their action on HSC expansion: act by biologic molecules, act on surface phenotype (CD34+), and act on signaling pathway. Biologic molecules act by producing bioactivators to create necessary substances to expand HSCs. CD34+ is the typical phenotype that stimulates HSC expansion. The signaling pathway has been previously discussed.

References

    1. Cha S.Y., Choi Y.H., Hwang S., Jeong J.Y., An H.J. Clinical impact of microRNAs associated with cancer stem cells as a prognostic factor in ovarian carcinoma. J. Cancer. 2017;8:3538–3547. doi: 10.7150/jca.20348. - DOI - PMC - PubMed
    1. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505:327–334. doi: 10.1038/nature12984. - DOI - PMC - PubMed
    1. Kaur S., Sehgal A., Wu A.C., Millard S.M., Batoon L., Sandrock C.J., Ferrari-Cestari M., Levesque J.P., Hume D.A., Raggatt L.J., et al. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice. J. Hematol. Oncol. 2021;14:3. doi: 10.1186/s13045-020-00997-w. - DOI - PMC - PubMed
    1. Girotra M., Trachsel V., Roch A., Lutolf M.P. In vivo pre-instructed hscs robustly execute asymmetric cell divisions in vitro. Int. J. Mol. Sci. 2020;21:8225. doi: 10.3390/ijms21218225. - DOI - PMC - PubMed
    1. Hofmeister C.C., Zhang J., Knight K.L., Le P., Stiff P.J. Ex vivo expansion of umbilical cord blood stem cells for transplantation: Growing knowledge from the hematopoietic niche. Bone Marrow Transplant. 2007;39:11–23. doi: 10.1038/sj.bmt.1705538. - DOI - PubMed

LinkOut - more resources